Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Assessing the Synergistic effect of Vitamin supplementation and Migraine preventative management in children and adolescents with chronic migraine- retrospective cohort analysis

Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis

Author:Arnold, Douglas L.   Freeman, Leorah   Hartung, Hans-Peter   Montalbán, Xavier   Cohen, Jeffrey A.   Bar-Or, Amit   Steinman, Lawrence   DeLuca, John   Cheng, Chun-Yen   Riolo, Jon V.   Silva, Diego   Pachai, Chahin   Cree, Bruce A. C.   

Session Name:P5: MS Prognosis/Epidemiology  

Topic:MS and Inflammatory Disease  

Program Number:P5.010  

Author Institution:NeuroRx Research and Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada, Montréal, QC, Canada  Dell Medical School, The University of Texas at Austin, Austin, Texas, Austin, TX  Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany  Brain and Mind Centre, University of Sydney, Australia  Department of Neurology, Medical University of Vienna, Austria  and Palacký University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic  Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Center for Neuroinflammation and Experimental Therapeutics, and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, Philadelphia, PA  Department of Neurology and Neurological Sciences, Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, California, Stanford, CA  Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, Newark, NJ  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA  

The Synuclein-One Study: Skin Biopsy Detection of Phosphorylated alpha-synuclein for Diagnosis of the Synucleinopathies

Author:Gibbons, Christopher   Bellaire, Bailey   Wang, Ningshan   Freeman, Roy   Adler, Charles   Miglis, Mitchell   Isaacson, Stuart   Evidente, Virgilio Gerald   Soileau, Michael   Gudesblatt, Mark   Lamotte, Guillaume   Kumar, Rajeev   Petrossian, Melita   Gonzalez Duarte, Maria Alejandra   Khemani, Pravin   Saint-Hilaire, Marie-Helene   McFarland, Nikolaus   Pandey, Hemant   Yerstein, Oleg   Barboi, Alexandru   Liu, Andrew   Levine, Todd   

Session Name:S37: Movement Disorders: Phenotyping and Biomarkers  

Topic:Movement Disorders  

Program Number:S37.004  

Author Institution:Beth Israel Deaconess Medical Center, Boston, MA  CND Life Sciences, Phoenix, AZ  BIDMC, Boston, MA  Beth Israel Deaconess Hosp, Boston, MA  Mayo Clinic Arizona, Scottsdale, AZ  Stanford University Medical Center, Stanford, CA  Parkinson’s Disease and Movement Disorders Center of Boca Raton, Boca Raton, FL  Movement Disorders Center of Arizona, Scottsdale, AZ  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  South Shore Neurologic Associates, Patchogue, NY  University of Utah, Salt Lake City, UT  Rocky Mountain Movement Disorders Center, Englewood, CO  Pacific Movement Disorders Center, Santa Monica, CA  NYU, new york, NY  Swedish Neuroscience Institute, Seattle, WA  Boston University School of Medicine, Roxbury, MA  University of Florida, Gainesville, FL  Brain and Spine Center, CHANDLER, AZ  Lahey Hospital & Medical Center, Burlington, MA  NorthShore University, Glenview, IL  Duke Health, Durham, NC  Honor Health, Scottsdale, AZ